quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:31:28·1053d
NEWSRelease
Bellerophon Therapeutics Inc. logo
Castle Biosciences Inc. logo
Elevation Oncology Inc. logo
+9

12 Health Care Stocks Moving In Monday's Intraday Session

BLPH· Bellerophon Therapeutics Inc.CSTL· Castle Biosciences Inc.ELEV· Elevation Oncology Inc.HTGM· HTG Molecular Diagnostics Inc.INVO· INVO BioScience Inc.KTTA· Pasithea Therapeutics Corp.
Health CareIndustrials
Original source

Companies

  • BLPH
    Bellerophon Therapeutics Inc.
    Health Care
  • CSTL
    Castle Biosciences Inc.
    Health Care
  • ELEV
    Elevation Oncology Inc.
    Health Care
  • HTGM
    HTG Molecular Diagnostics Inc.
    Industrials
  • INVO
    INVO BioScience Inc.
    Health Care
  • KTTA
    Pasithea Therapeutics Corp.
    Health Care
  • MNK
    Mallinckrodt plc
    Health Care
  • PDSB
    PDS Biotechnology Corporation
    Health Care
  • REPL
    Replimune Group Inc.
    Health Care
  • RGC
    Regencell Bioscience Holdings Limited
    Health Care
  • SCLX
    Scilex Holding Company
    Health Care
  • TMBR
    Timber Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Apr 13REPLUpdateBMO Capital Markets$1.00
  • Apr 13REPLUpdateJefferies$2.00
  • Apr 13REPLUpdateAnalyst-
  • Apr 13REPLUpdateH.C. Wainwright-
  • Apr 13REPLUpdateLeerink Partners$2.00
  • Apr 13REPLUpdateWedbush$2.00

Related

  • INSIDER9h
    Pres. & Chief Exec. Officer Maetzold Derek J exercised 550 shares at a strike of $2.39 and sold $104,709 worth of shares (4,172 units at $25.10) as part of a pre-agreed trading plan (SEC Form 4)
  • PR2d
    Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
  • PR3d
    Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026
  • INSIDER3d
    SEC Form 4 filed by Ma Stephen Hoi
  • INSIDER3d
    SEC Form 4 filed by Ji Henry
  • PR3d
    Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)
  • INSIDER6d
    SEC Form 3 filed by new insider Coastlands Capital Lp
  • SEC6d
    SEC Form 6-K filed by Regencell Bioscience Holdings Limited
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022